{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006915",
      "entity_text" : "apoptosis",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P10415",
      "entity_text" : "Bcl-2",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The overexpression of Bcl-2 contributes to cancer progression, inhibits apoptosis and confers resistance to standard anticancer therapies, limiting treatment options for AML.",
  "reading_complete" : "2020-08-02T14:25:13Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T14:24:29Z",
  "trigger" : "inhibits",
  "evidence" : [ "Bcl-2 contributes to cancer progression, inhibits apoptosis" ],
  "pmc_id" : "4533783",
  "score" : 0
}